The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Open accessAbstract
Although tumor-specific T cells recognize cancer cells, they are often rendered dysfunctional due to an immunosuppressive microenvironment. Here we showed that T cells demonstrated persistent loss of mitochondrial function and mass when infiltrating murine and human tumors, an effect specific to the tumor microenvironment and not merely caused by activation. Tumor-infiltrating T cells showed a progressive loss of PPAR-gamma coactivator 1α (PGC1α), which programs mitochondrial biogenesis, induced by chronic Akt signaling in tumor-specific T cells. Reprogramming tumor-specific T cells through enforced expression of PGC1α resulted in superior intratumoral metabolic and effector function. Our data support a model in which signals in the tumor microenvironment repress T cell oxidative metabolism, resulting in effector cells with metabolic needs that cannot be met. Our studies also suggest that modulation or reprogramming of the altered metabolism of tumor-infiltrating T cells might represent a potential strategy to reinvigorate dysfunctional T cells for cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exhausted T cells and tumor-infiltrating NK cells also exhibit dysregulated mitochondrial biogenesis, a mechanism that has created interest in using strategies to improve mitochondrial biogenesis to promote tumor immunity (Scharping et al., 2016; Zheng et al., 2019).”
From Hallmarks of response, resistance, and toxicity to immune checkpoint blockade (2021) · cites this paper as Scharping et al., 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular and cellular insights into T cell exhaustion
Wherry, E. J., & Kurachi, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3862 · Cited by 4,652
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2006) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,827
Mitochondria as sensors and regulators of calcium signalling
Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3412 · Cited by 1,781
Woo, S.-R., Turnis, M. E., Goldberg, M. V., Bankoti, J., Selby, M., Nirschl, C. J., Bettini, M. L., Gravano, D. M., Vogel, P., Liu, C. L., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1620 · Cited by 1,647
Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development
van der Windt, G. J. W., Everts, B., Chang, C.-H., Curtis, J. D., Freitas, T. C., Amiel, E., Pearce, E. J., & Pearce, E. L. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.007 · Cited by 1,540
Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
Ho, P.-C., Bihuniak, J. D., Macintyre, A. N., Staron, M., Liu, X., Amezquita, R., Tsui, Y.-C., Cui, G., Micevic, G., Perales, J. C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.012 · Cited by 1,462
PGC-1 coactivators: inducible regulators of energy metabolism in health and disease
Finck, B. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27794 · Cited by 1,461
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363
Combination cancer immunotherapy and new immunomodulatory targets
Mahoney, K. M., Rennert, P. D., & Freeman, G. J. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4591 · Cited by 1,294
Flagged first, then by citations
Research works printed but not linked: 1
- Scarpulla, 2011, Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochimica et Biophysica Acta (BBA) -, Molecular Cell Research, 1813, 1269
Cited by
Sorted by citations
Items 701–800 of 847
Inducing an oxidized redox-balance improves anti-tumor CD8 + T cell functionPreprint
Oh, J. H., Cederberg, R. A., Tanaka, E., Bopp, L., Ser, T., Niyyati, S., Patterson, A. E., Amanat, N., Dutra, J., Ye, P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.27.533229 · Cited by 2
A PD-1-ST2 axis controls Th2 effector function in tissue via a metabolic checkpointPreprint
Heieis, G. A., Everts, B., Roberts, C. W., Maizels, R. M., & Perona‐Wright, G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.13.553117 · Cited by 1
Hunt, E. G., Hurst, K. E., Kennedy, A. S., Riesenberg, B., Gandy, E. J., Andrews, A. M., Gao, P., Coleman, M. F., Wallace, E. D., & Thaxton, J. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.16.567439 · Cited by 1
Genetics and Epigenetics of Type 1 Diabetes Self-Reactive T CellsPreprint
Kang, T. G., & Youngblood, B. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041586 · Cited by 2
Jurgens, A. P., Popović, B., van Alphen, F. P. J., Wardak, L., Bradarić, A., Engels, S., van der Zwaan, C., van den Biggelaar, M., Hoogendijk, A. J., Béthune, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.25.666749 · Cited by 1
Heaton, A. R., Burkard, N. J., Gao, A., Hoefges, A., Feils, A. S., Burkard, S. K., Felder, M. A. R., Tsarovsky, N. W., Spiegelman, D. V., Lublin, G. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.24.684274 · Cited by 1
Contribuição da atividade física aeróbia para a resposta imune antitumoral
Tobias, G. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.39.2018.tde-08012018-102525
Intracellular Sensors and Cellular Metabolism in Allogeneic Hematopoietic Stem Cell Transplantation
Byersdorfer, C. A., & Reddy, P. R. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812630-1.00019-0
CAR T-Cell Therapy for CNS Malignancies
Sanber, K. S., Joseph, S. K., & Ahmed, N. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-66181-2.00012-3
Lin, H., Zhen, H., Shan, K., Ma, X., & Cao, B. (2020) · Research Square · doi:10.21203/rs.3.rs-56379/v1
Targeting metabolism to potentiate NK cell-based therapies
Dhar, P., & Wu, J. D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824375-6.00016-3
Immunometabolism and Organ Transplantation
Domínguez-Amorocho, O. A., de Lima, J., & Câmara, N. O. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-86684-6_13
Metabolic Profile of Adaptive Immune Cells
Domínguez-Amorocho, O. A., Soto‐Heredero, G., & Mittelbrunn, M. (2021) · Springer eBooks · doi:10.1007/978-3-030-86684-6_6
Hope, J. L., Otero, D. C., Bae, E., Stairiker, C. J., Palete, A. B., Faso, H. A., Henriquez, M. L., Seo, H., Lei, X., Wang, E. S., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.24.477602
Methionine uptake via SLC43A2 transporter is essential for regulatory T lymphocyte survivalPreprint
Naaz, A., Saini, N., Padma, S., Gahlot, P., Walvekar, A. S., Dutta, A., Davathamizhan, U., Sarin, A., & Laxman, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.09.483598
Tsokos, G. C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727394204.793570386
Faculty Opinions recommendation of Signaling networks in immunometabolism.
Kane, L. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737610223.793578145
Targeting Immune Cell Metabolism for the Improvement of Cancer Therapy
Liu, W. (2022) · International Conference on Biotechnology, Life Science and Medical Engineering (BLSME) · doi:10.23977/blsme.2022037
Gnanaprakasam, J. R., Liu, L., Chen, X., Kang, S., Wang, T., Cassel, T., Adams, C. M., Higashi, R. M., Scott, D. A., Xin, G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.18.500458
Apétoh, L. (2022) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2022.07.017
Ishtiaq, S. M., Arshad, M. I., & Khan, J. A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4192515
Nanotechnology to Correct Mitochondrial Disorders in Cancer Diseases
Faria, R., Albuquerque, T., Neves, A. R., Sousa, Â., & Costa, D. R. B. (2022) · Springer eBooks · doi:10.1007/978-3-031-17831-3_6
Targeting CAR T Cells’ Metabolic Pathways to Boost Their Effectiveness Against Tumors
Khakpoor-Koosheh, M., Rostamian, H., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_188-1
王, 铮. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.131145
Liu, J., He, M., Liu, Y., Liu, M., Wang, H., Gu, W., Gao, Y., Li, Z., & Song, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2691058/v1
Chakraborty, P., Parikh, R. Y., Choi, S., Tran, D., Gooz, M. B., Hedley, Z. T., Kim, D., Pytel, D., Kang, I., Nadig, S. N., et al. (2023) · doi:10.1158/0008-5472.c.6513793.v1
Chakraborty, P., Parikh, R. Y., Choi, S., Tran, D., Gooz, M. B., Hedley, Z. T., Kim, D., Pytel, D., Kang, I., Nadig, S. N., et al. (2023) · doi:10.1158/0008-5472.c.6513793
Triozzi, P. L., Stirling, E. R., Song, Q., Westwood, B. M., Kooshki, M., Forbes, M. E., Holbrook, B. C., Cook, K. L., Alexander‐Miller, M. A., Miller, L. D., et al. (2023) · doi:10.1158/1078-0432.c.6532389
Qiao, G., Chen, M., Mohammadpour, H., MacDonald, C. R., Bucsek, M. J., Hylander, B. L., Barbi, J. J., & Repasky, E. A. (2023) · doi:10.1158/2326-6066.c.6550284.v1
Data from Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells
Drijvers, J. M., Gillis, J. E., Muijlwijk, T., Nguyen, T. H. P., Gaudiano, E. F., Harris, I. S., LaFleur, M. W., Ringel, A. E., Yao, C.-H., Kurmi, K., et al. (2023) · doi:10.1158/2326-6066.c.6550425.v1
Data from TCR-Independent Metabolic Reprogramming Precedes Lymphoma-Driven Changes in T-cell Fate
Hesterberg, R. S., Liu, M., Elmarsafawi, A. G., Koomen, J. M., Welsh, E. A., Hesterberg, S. G., Ranatunga, S., Yang, C., Li, W., Lawrence, H. R., et al. (2023) · doi:10.1158/2326-6066.c.6550956.v1
Slaats, J., Dieteren, C. E. J., Wagena, E., Wolf, L. E., Raaijmakers, T. K., van der Laak, J. A. W. M., Figdor, C. G., Weigelin, B., & Friedl, P. (2023) · doi:10.1158/2326-6066.22544286
Slaats, J., Dieteren, C. E. J., Wagena, E., Wolf, L., Raaijmakers, T. K., van der Laak, J. A. W. M., Figdor, C. G., Weigelin, B., & Friedl, P. (2023) · doi:10.1158/2326-6066.22544304
Adhikari, U. D., Shah, P. V., Froehle, L., Linder, A. H., Flagg, M., Rawlings, C. A., Junca, M. R., Folarin, L., Karim, F., Li, J. Z., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.02.539176
Ma, Y., Fang, F., Liao, K., Zhang, J., Chen, W., Liao, Y., Zhao, B., Fang, Y., Chen, Y., Wang, D., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2896492/v1
Nirschl, C. J., Brodkin, H. R., Domonkos, C., Dwyer, C. J., Hicklin, D. J., Ismail, N. S., Seidel‐Dugan, C., Steiner, P., Steuert, Z., Sullivan, J. M., et al. (2023) · doi:10.1158/2326-6066.c.6653474
402 Mitophagy reinvigorates exhausted CD8 T cell
Zhang, R., Sun, N., & Xin, G. (2023) · Regular and Young Investigator Award Abstracts · doi:10.1136/jitc-2023-sitc2023.0402
Ando, M., Kondo, T., Nakagawara, K., Mise‐Omata, S., & Yoshimura, A. (2023) · Research Square · doi:10.21203/rs.3.rs-3639314/v1
Slavkovic‐Lukic, D., Fioravanti, J., Martín-Santos, A., Han, E., Zhou, J., & Gattinoni, L. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3593-3_11
Boșoteanu, L.-A., Gheorghe, E., Aşchie, M., Cozaru, G. C., Deacu, M., Bălţătescu, G. I., Orǎșanu, C. I., & Boşoteanu, M. (2023) · Medicina · doi:10.3390/medicina59122151
Immune System, Redox Signaling, and Cancer Immunity
Bansal, M. P. (2023) · Springer eBooks · doi:10.1007/978-981-99-7342-2_6
Zeng, H., Zhu, X., Wu, Y., Li, Y., Zhou, X., Watzlawik, J. O., Chen, Y. M., Raybuck, A. L., Billadeau, D. D., Shapiro, V. S., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3957355/v1
Oxidative stress in gut TH17 cells makes mice susceptible to bacterial infection
O’Shaughnessy, S., & Finlay, D. K. (2024) · Immunometabolism · doi:10.1097/in9.0000000000000049
Modulating T cell metabolism to improve T cell therapy
Li, Y., Hung, S.-H., Singh, S., & Yee, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13827-0.00008-1
T cell metabolism and cancer immunotherapy
Li, Q., & Zhang, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13827-0.00006-8
Ramos, A., Simon, S., Siller‐Farfán, J. A., Rajan, A., Revale, S., di Castiglionchio, E. Z., Pelea, O., Fulga, T. A., Riddell, S. R., Dushek, O., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.10.637482
Wang, Q., Yin, X., Liu, H., Wang, Q., Zhang, L., Wang, Y., & Lu, H. (2025) · Oncology Letters · doi:10.3892/ol.2025.15019
CAR T cells and metabolic programming: A review
Hatami, S., Kazemi, F., Doroudgar, P., Shushtari, S. S., & Atashzar, M. R. (2025) · Medical Immunology (Russia) · doi:10.15789/1563-0625-ctc-3155
Cellular Metabolism Controls Lymphocyte Activation and Differentiation
Powell, J. D., & Sun, I. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00180-0
Immunometabolism Governs T Cell Immunity
Raynor, J. L., Shi, H., & Chi, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00275-1
Bai, X., Wang, H., & Guo, Q. (2025) · Immunological Medicine · doi:10.1080/25785826.2025.2560214
Clonal expansion of cytotoxic CD8 + T cells in lecanemab-associated ARIAPreprint
Johnson, L. A., Saito, K., Pallerla, A. V., Funnell, J. L., Ezzo, A. R., Song, C. L., Harrison, D. A., Norton, N. J., Moore, L. C., Eldik, L. J. V., et al. (2025) · medRxiv · doi:10.1101/2025.09.17.25335728
Liu, H., Luo, X., Sun, H., Pan, J., Ding, S., Zhou, Z., & Sun, M. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.168843
Targeting CAR T Cells’ Metabolic Pathways to Boost Their Effectiveness Against Tumors
Khakpoor-Koosheh, M., Rostamian, H., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00767-4_188
Mitochondria redistribution organizes the immunosuppressive tumor ecosystemPreprint
Terasaki, A., Weiner, A. T., Tan, Y., Szeifert, V., Bhatnagar, K., Rada, C. C., Shankar, V., Kernick, C., Mahmood, M., Wiggers, L., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.11.687895
Aquilani, R., Corallo, S., Maestri, R., Brugnatelli, S., Iadarola, P., Viglio, S., Figini, S., Filippi, B., Alaimo, D., Sporeni, S., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-26219-2
Peng, Q., Zhang, M., Zhao, S., Guo, Y., Shan, M., Su, B., Mao, S., Shi, D., & Lin, Z. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102652
Sadeghirad, H., Monkman, J. H., Tan, C. W., Liu, N., Yunis, J., Donovan, M. L., Moradi, A., Jhaveri, N., Perry, C., Adams, M. N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753260
Sadeghirad, H., Monkman, J. H., Tan, C. W., Liu, N., Yunis, J., Donovan, M. L., Moradi, A., Jhaveri, N., Perry, C., Adams, M. N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753254
Sadeghirad, H., Monkman, J. H., Tan, C. W., Liu, N., Yunis, J., Donovan, M. L., Moradi, A., Jhaveri, N., Perry, C., Adams, M. N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26753257
Sadeghirad, H., Monkman, J. H., Tan, C. W., Liu, N., Yunis, J., Donovan, M. L., Moradi, A., Jhaveri, N., Perry, C., Adams, M. N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26367926
Sadeghirad, H., Monkman, J. H., Tan, C. W., Liu, N., Yunis, J., Donovan, M. L., Moradi, A., Jhaveri, N., Perry, C., Adams, M. N., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26368537
Overcoming Challenges of CAR T-Cell Therapy in Solid Tumor Microenvironments
Garg, R. I., Charan, S., Pal, D., Kumar, U., Rai, A., Singh, R., & Medhi, B. (2026) · Springer eBooks · doi:10.1007/978-981-95-3628-3_7
Mitigating bias in spatial transcriptomic pipelines via human feedback with CSDE
Boyeau, P., Bates, S., Ergen, C., Jordan, M. I., & Yosef, N. (2026) · Genome biology · doi:10.64898/2026.01.15.699786 · Cited by 1
Transcriptional and Epigenetic Regulation of T Cell States in Cancer
Ma, S., Hargreaves, D. C., & Kaech, S. M. (2026) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061325-042744
Grindstaff, E. J., Rayyan, L. A., Alwarawrah, Y., Rezeli, E. T., MacIver, N. J., Teegarden, D., Hursting, S. D., & Bustamante-Marin, X. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.08.704727
Tuning tissue-resident memory T cells to fuel cancer immunotherapy
Zhang, Y., Fang, Y.-X., Xiao, Y., Li, S., & Sun, Z.-J. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116308
Fu, J., Tao, Y., & Wu, L. (2026) · Scientific Reports · doi:10.1038/s41598-026-40547-x
Zhong, G., Liu, B., Gong, X., Wang, Q., Zheng, S., Luo, X., Chen, Z., Zhang, X., Hu, B., & Wu, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1733753
Dual roles of immunosenescence in cancer immunotherapy
Yu, Y., Sun, L., & Fan, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1779141
Li, S., Shiekh, P. A., Li, Y.-R., Nan, H., Yang, L., Mitchell, K., Yang, Y., & Zhu, Y. (2026) · Research Square · doi:10.21203/rs.3.rs-8296891/v1
Novel mechanisms in tolerogenic dendritic cells
Millán, E. A. M. (2018) · theses.fr (ABES) · doi:10.70675/d9d0f840z6f45z48aeza5b4z666ecad22729
Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activityPreprint
Pumar, O. T., VanNoy, E. L., Haffey, A., Gannamedi, D. P., Rafie, C. I., Harwood, D. S. L., Benedetti, J. R., Ballard, C. A. P., Ciervo, E., Coroa, P. H. A. T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.31.715681
Défauts fonctionnels des cellules NK en contexte de stimulation chronique
Marotel, M. (2019) · theses.fr (ABES) · doi:10.70675/1dcb97a5za482z4664zaaf6z62a53817eea9
Mittelheisser, V. (2024) · theses.fr (ABES) · doi:10.70675/92b9630bz16afz4843z93caz705680f2ac69
Li, X., Zhang, Y., Yang, Q., Gong, J., Zhang, N., Huang, Y., Chen, T., Zhou, D., Zou, Z., & Guo, Z. (2026) · Inflammation Research · doi:10.1007/s00011-026-02243-4
Genomics-Driven Immunotherapy: Advancing Cancer Treatment through Personalized Approaches
Kate, A. A., Desai, S. A., Sapkal, S. P., More, M. J., & Patel, V. P. (2026) · Current Genomics · doi:10.2174/0113892029403241260416110923
Jeysankar, P., Srikanth, S., Wu, B., & Gwack, Y. (2026) · Journal of Cancer Immunology · doi:10.33696/cancerimmunol.8.120
Bostwick-Galaviz, A. M., & Usherwood, E. J. (2026) · The Journal of Immunology · doi:10.1093/jimmun/vkag035
Alatoom, A., Sapudom, J., Elkhoury, K., Deliorman, M., Khair, M., Vijayavenkataraman, S., Qasaimeh, M. A., & Teo, J. C. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.22.720068
Ren, Q., Ou, Q., Li, Z., Niu, L., Tang, D., Liu, X., Mao, X., & Shi, S. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04466-3
Qin, J., He, Y., Yang, Y., Yang, J., Liu, Z., Xie, Y., Lu, W., Liu, M., Zhao, Z., Cai, D., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1819923
Mitochondrial metabolism as a pharmacological target for cancer therapeutics
Yu, Y., Ding, W., Liu, S., Glorieux, C., Liu, P., & Huang, P. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100137
Wang, R., Zhang, X., Ren, B., & Zhou, W. C. (2026) · Human Genomics · doi:10.1186/s40246-026-00970-7
Yue, J., Chen, M., Xiong, Z., Qiu, J., Liu, Y., & Chen, L. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s595199 · Cited by 1
From guardians to traitors: molecular mechanisms of tumor-induced T cell betrayal
Ye, P., 匡洪宇, Lin, A., Tang, B., Wang, Q., Zhang, H., Wong, H. Z. H., Zhang, J., Cheng, Q., Glaviano, A., et al. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02669-8
Zhao, R., Li, Y., Zhu, R., Zong, R., Sun, M., Liu, M., & Guo, H. C. (2026) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2026.105385
Mokhashi, O., Gao, L., Xin, R., Chhabra, R., Hale, S., Wang‐Rodriguez, J., & Ongkeko, W. M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.26.728017
Delacruz, L. R., Ye, M., Libby, K. A., Han, K., Munger, C. J., QIU, Y., Kurland, I. J., & Ringel, A. E. (2026) · eLife · doi:10.64898/2026.06.01.729353
Next-Generation Immunotherapy Strategies Driven by Tumor Microenvironment Modulation
Hui, X., Gao, G., Ding, S., Gao, S., Jiaqi, T., Xu, S., Tiesuo, Z., & Wang, H. (2026) · Immune discovery. · doi:10.70322/immune.2026.10003
3M-052 combined inhibitory anti-TNFR2 synergistically suppresses colon cancer progression
Jing, Q., Luo, J., Wan, Q., Jing, Q., Hu, X., Nei, C., Zhang, X., Zhou, Y., Tang, J., Wang, Y., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1749062
Mitochondrial dynamics and T cells immunity in cancer
Li, X., Zhang, M., Wang, Y., Li, M., Wang, T., & Liu, X. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102659
Goedhart, N. B., Camerini, E., Cretenet, G., Grootemaat, A. E., Vlaskov, K., Jacobs, C. F., d’Hargues, Y., van der Wel, N. N., Vrieling, F., Schomakers, B. V., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.09.731122
CCL20-CCR6 axis in autoimmune disease and cancer progression: clinical and therapeutic implications
Gr, Y., Zhang, A., Liu, Y., Fan, T., Wen, X. L., Li, C., & Jiang, Z. H. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02969-y
Zhang, W., Yuan, W., Yuan, C., Cheng, Y., Zhang, D., Cao, X., & Ding, C. (2026) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2026.06.004
T cell activation and TCRs as an immunotherapeutic approach in cancer
Güney-Kalkan, S. (2026) · Letters in Drug Design & Discovery · doi:10.1016/j.lddd.2026.100450
Small Molecule Activators of Antitumor Immunity
Singh, V. P., & Uesugi, M. (2026) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6c00316
Mitochondrial Ca2+ signaling: A metabolic rheostat defining tumor and immune cell fate
Bura, A. E., Rolong, A., Paget, C., & Guéguinou, M. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.05.012
Metadata
- Authors
- Scharping, N. E., Menk, A. V., Moreci, R. S., Whetstone, R. D., Dadey, R. E., Watkins, S. C., Ferris, R. L., & Delgoffe, G. M.
- Affiliations
- University of Pittsburgh (US)
- UPMC Hillman Cancer Center (US)
- Corresponding author
- Delgoffe, Greg M.
- ORCID
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 45
- Issue
- 2
- Pages
- 374-388
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC5207350
- OpenAlex
- W4294138012
- Cited by
- 848
- References
- 44
- Citations by year
- 2026: 136 · 2025: 111 · 2024: 113 · 2023: 97 · 2022: 109 · 2021: 90 · 2020: 76 · 2019: 42 · 2018: 33 · 2017: 34 · 2016: 7
- FWCI
- 20.82
- Type
- journal article
- Language
- en
- Update notices
- erratum (2016-09-20)
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (1s10od016236-01)
- National Cancer Institute (P50CA121973, P50CA097190, P30CA047904)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- tumor microenvironment, PGC-1α, Akt signaling, T cell metabolism, oxidative metabolism, tumor-infiltrating T cells, T cell dysfunction, immunosuppression, metabolic reprogramming, cancer immunotherapy
- MeSH terms
- Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Animals, Colonic Neoplasms, Humans, Mice, Inbred C57BL, Mice, Transgenic, Mitochondria, Neoplasms, Experimental, T-Lymphocytes, Signal Transduction, Lymphocytes, Tumor-Infiltrating, Oxidative Stress, Cell Line, Tumor, PPAR gamma, Oncogene Protein v-akt, Mice, Tumor Microenvironment, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review